FDA Inspection 1293416 — Yashvant G. Khaire
The FDA completed an inspection of Yashvant G. Khaire on November 13, 2025 in Navi Mumbai. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 13, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Navi Mumbai (India)
Additional Details
Clinical BA/BE